SCHLEIFER LEONARD S (President & CEO) exercised options at REGENERON PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 12/11/2025ACC: 0001218629-25-000006
DirectorOfficer· President & CEO
Since Dec 2018
-155.15K
Net shares
Net seller
$108.84M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
172.72K acquired · 327.87K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+172.72K
Price / share
$555.67
Trade value
$95.98M
% of position
87.7%
12/9/2025
196.94K→369.67K
Common Stock
Direct
Shares
−155.15K
Price / share
$701.51
Trade value
$108.84M
% of position
42.0%
12/9/2025
369.67K→214.52K
Total
Net shares
+17.58K
Net value
-$12.86M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2025 | M · Option Exercise | +172.72K | $555.67 | $95.98M | 87.7% | 196.94K | 369.67K |
| Common Stock Direct | 12/9/2025 | F · Tax Withholding | −155.15K | $701.51 | $108.84M | 42.0% | 369.67K | 214.52K |
| Total | +17.58K | -$12.86M | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
172.72K shares
Shares
−172.72K
Strike price
555.67
Held after
0.00
Exercisable
—
12/9/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock172.72K shares | 12/9/2025 | M · Option Exercise | −172.72K | 555.67 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned127.48K
Common Stock
IndirectShares owned39.98K
Common Stock
IndirectShares owned300K
Common Stock
IndirectShares owned5.99K
Total
473.46K indirect473.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 127.48K | Indirect |
| Common Stock | 39.98K | Indirect |
| Common Stock | 300K | Indirect |
| Common Stock | 5.99K | Indirect |
| Total | 473.46K | 473.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported